Nanoviricides NNVC Cash Flow Statement (2010-2026)

NYSE NNVC
$1.51 +0.03 (+2.03%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Nanoviricides Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Nanoviricides reported cash from operations of -$2.10M and free cash flow of -$2.10M for the quarter ended Jun 2026, down 23.4% year over year. This cash flow statement covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.61M-1.92M-1.79M-1.78M-1.57M-1.75M-1.70M-3.57M-1.97M-2.11M-1.85M-2.36M-3.13M-2.03M-2.22M-2.10M-1.79M-2.22M-1.99M-2.22M
Depreciation and DepletionDep. & Depletion
0.17M0.18M0.18M0.19M0.18M0.18M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.16M0.13M0.13M0.13M0.13M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.17M0.18M0.18M0.19M0.18M0.18M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.19M0.16M0.13M0.13M0.13M0.13M
Share-based CompensationStock Comp.
0.04M0.04M0.05M0.07M0.04M0.04M0.04M0.04M0.06M0.04M0.04M0.04M0.05M0.04M0.04M0.04M0.04M0.19M0.06M0.04M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
0.03M0.04M0.04M0.03M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account PayablesChange Payables
0.67M-0.54M-0.21M0.26M0.22M-0.06M-0.13M0.07M0.15M0.12M-0.09M0.30M0.34M-0.19M-0.05M0.01M0.08M-0.32M-0.08M0.19M
Change in Accured ExpensesChange Accured Exp.
-210.0082.000.00M0.02M-0.02M0.03M-0.01M0.10M0.20M-0.11M0.08M0.00M0.02M-0.25M0.00M-0.01M331.000.02M-0.02M0.01M
Change in Other Operating AssetsOther Assets Change
-0.11M-0.05M0.01M0.01M-0.13M-0.14M0.17M0.01M-0.12M-0.11M0.20M-0.09M0.00M-0.07M0.07M-0.07M0.01M0.02M0.02M0.20M
Other Working Capital ChangesOther WC Changes
0.11M0.05M-0.01M-0.01M0.13M0.14M-0.17M-0.01M0.12M0.11M-0.20M0.09M0.00M0.07M-0.07M0.07M-0.01M-0.02M-0.02M-0.20M
Cash from OperationsCash from Ops.
-0.72M-2.11M-1.66M-1.40M-1.03M-1.40M-1.74M-1.50M-1.17M-1.72M-1.94M-1.48M-2.59M-2.19M-1.99M-1.70M-1.60M-2.04M-1.96M-2.10M
Investing Activities
Capital ExpendituresCapex
0.02M0.19M0.04M0.08M0.04M0.05M0.06M0.00M0.01M0.01M0.04M0.10M0.05M0.01M0.08M-1.001.00
Change in Property, Plant and EquipmentChange in PP&E
-0.02M-0.19M-0.04M-0.08M-0.04M-0.05M-0.06M0.00M-0.01M-0.01M-0.04M-0.10M-0.05M-0.01M-0.08M1.00-1.00
Change in IntangiblesChange Intangibless
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
0.00M-0.01M-0.01M-0.04M-0.10M-0.05M-0.01M-0.08M1.00-1.00
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.07M0.02M0.07M0.07M0.07M0.02M
Non-Current Debt
-0.07M-0.02M-0.07M-0.07M-0.07M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.07M-0.02M-0.07M-0.07M-0.07M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
3.12M1.71M2.28M0.58M0.73M1.25M0.66M
Net Shares Issued and RepurchasedNet Shares Issued
3.12M1.71M2.28M0.58M0.73M1.25M0.66M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
3.12M1.71M2.28M0.58M0.73M1.25M0.66M
Other financing activitiesOther financing
-0.04M
Cash from Financing ActivitiesCash from Financing
-0.07M-0.06M-0.07M-0.03M-0.07M-0.02M3.12M1.71M2.28M0.58M0.73M1.25M6.07M-0.01M1.70M
Additional items
Change in Cash
-0.82M-2.36M-1.76M-1.51M-1.15M-1.47M-1.80M-1.50M-1.18M-1.72M-1.99M1.54M-0.93M0.09M-1.42M-0.98M-0.43M4.02M-1.94M-0.42M
Ending Cash Balance
19.70M17.34M15.57M14.07M12.92M11.45M9.65M8.15M6.97M5.25M3.26M4.80M3.87M3.96M2.54M1.56M1.13M5.15M3.21M2.79M
Free Cash FlowFCF
-0.75M-2.30M-1.69M-1.47M-1.08M-1.45M-1.80M-1.50M-1.18M-1.72M-1.99M-1.58M-2.64M-2.19M-1.99M-1.71M-1.68M-2.04M-1.96M-2.10M
Net Cash FlowNCF
-0.80M-2.18M-1.72M-1.43M-1.10M-1.42M-1.74M-1.50M-1.18M-1.72M-1.99M1.54M-0.93M0.09M-1.42M-0.98M-0.44M4.03M-1.96M-0.40M
Interest Paid
892.0051.000.00M0.00M844.0094.00

Nanoviricides Cash Flow Statement API

Pull Nanoviricides's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NNVC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY